View of Integrated in silico and in vitro profiling of newly designed heterocyclic thiazolidinone targeting androgen-independent prostate cancer

Return to Article Details Integrated in silico and in vitro profiling of newly designed heterocyclic thiazolidinone targeting androgen-independent prostate cancer Download Download PDF